Schlitzer M - Search Results

1

Structure-based optimization of aldose reductase inhibitors originating from virtual screening.

Eisenmann M, Steuber H, Zentgraf M, Altenkämper M, Ortmann R, Perruchon J, Klebe G, Schlitzer M. Eisenmann M, et al. Among authors: schlitzer m. ChemMedChem. 2009 May;4(5):809-19. doi: 10.1002/cmdc.200800410. ChemMedChem. 2009. PMID: 19301313

2

Design, synthesis and early structure-activity relationship of farnesyltransferase inhibitors which mimic both the peptidic and the prenylic substrate.

Schlitzer M, Böhm M, Sattler I, Dahse HM. Schlitzer M, et al. Bioorg Med Chem. 2000 Aug;8(8):1991-2006. doi: 10.1016/s0968-0896(00)00138-3. Bioorg Med Chem. 2000. PMID: 11003144

3

Non-thiol farnesyltransferase inhibitors: structure-activity relationships of aralkylsubstituted benzophenones.

Mitsch A, Wissner P, Sattler I, Schlitzer M. Mitsch A, et al. Among authors: schlitzer m. Arch Pharm (Weinheim). 2001 Feb;334(2):40-4. doi: 10.1002/1521-4184(200102)334:2<40::aid-ardp40>3.0.co;2-w. Arch Pharm (Weinheim). 2001. PMID: 11268773

4

Synthesis of potential aldose reductase inhibitors based on minimal pharmacophore requirements.

Schlitzer M, Rodriguez L, Kador PF. Schlitzer M, et al. J Pharm Pharmacol. 2001 Jun;53(6):831-9. doi: 10.1211/0022357011776180. J Pharm Pharmacol. 2001. PMID: 11428659

5

Synthesis, molecular modeling, and structure-activity relationship of benzophenone-based CAAX-peptidomimetic farnesyltransferase inhibitors.

Sakowski J, Böhm M, Sattler I, Dahse HM, Schlitzer M. Sakowski J, et al. Among authors: schlitzer m. J Med Chem. 2001 Aug 30;44(18):2886-99. doi: 10.1021/jm010872r. J Med Chem. 2001. PMID: 11520197

6

Exploration of novel aryl binding sites of farnesyltransferase using molecular modeling and benzophenone-based farnesyltransferase inhibitors.

Böhm M, Mitsch A, Wissner P, Sattler I, Schlitzer M. Böhm M, et al. Among authors: schlitzer m. J Med Chem. 2001 Sep 13;44(19):3117-24. doi: 10.1021/jm010873j. J Med Chem. 2001. PMID: 11543680

7

Non-thiol farnesyltransferase inhibitors: N-(4-Acylamino-3-benzoylphenyl)-4-nitrocinnamic acid amides.

Sakowski J, Sattler I, Schlitzer M. Sakowski J, et al. Among authors: schlitzer m. Bioorg Med Chem. 2002 Feb;10(2):233-9. doi: 10.1016/s0968-0896(01)00274-7. Bioorg Med Chem. 2002. PMID: 11741771

8

Non-thiol farnesyltransferase inhibitors: structure-activity relationships of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.

Schlitzer M, Böhm M, Sattler I. Schlitzer M, et al. Bioorg Med Chem. 2002 Mar;10(3):615-20. doi: 10.1016/s0968-0896(01)00312-1. Bioorg Med Chem. 2002. PMID: 11814849

9

Non-thiol farnesyltransferase inhibitors: utilization of an aryl binding site by 5-arylacryloylaminobenzophenones.

Mitsch A, Böhm M, Wissner P, Sattler I, Schlitzer M. Mitsch A, et al. Among authors: schlitzer m. Bioorg Med Chem. 2002 Aug;10(8):2657-62. doi: 10.1016/s0968-0896(02)00088-3. Bioorg Med Chem. 2002. PMID: 12057654

10

Structure-activity relationships of novel anti-malarial agents: part 5. N-(4-acylamino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides.

Wiesner J, Kettler K, Sakowski J, Ortmann R, Jomaa H, Schlitzer M. Wiesner J, et al. Among authors: schlitzer m. Bioorg Med Chem Lett. 2003 Feb 10;13(3):361-3. doi: 10.1016/s0960-894x(02)01003-x. Bioorg Med Chem Lett. 2003. PMID: 12565929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters